Plasma nitrate values in patients with obsessive-compulsive disorder

Psychiatry and Clinical Neurosciences

Volumn 59, Issue 5, 2005, Pages 621-623

  Atmaca, Murad ^a   Tezcan, Ertan ^a   Kuloglu, Murat ^a   Ustundag, Bilal ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

Nitric; Obsessive compulsive disorder; Oxide; Pathophysiology

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; SEX RATIO;

ADOLESCENT; ADULT; AGING; FEMALE; HUMANS; MALE; NITRATES; NITRIC OXIDE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES;

EID: 28844504300     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2005.01426.x     Document Type: Article

References (11)

1. Schulman H. Nitric oxide: a spatial second messenger. Mol. Psychiatry 1997; 2: 296-299.
2. Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM. On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology 1999; 38: 1299-1306.
3. Akyol O, Herken H, Uz E et al. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/ antioxidant imbalance. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002; 26: 995-1005.
4. McDougle CJ, Foodman WK, Leckman JF. The psychopharmacology of obsessive-compulsive disorder. Implications for treatment and pathogenesis. Psychiatr. Clin. North Am. 1983; 16: 749-766.
5. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive compulsive disorder. Neuropsychobiology 2002; 46: 27-32.
6. Goodman WK, Price LH, Rasmussen SA. The yale-brown obsessive compulsive scale. Arch. Gen. Psychiatry 1989; 46: 1006-1016.
7. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Antioxidant enzyme and malondialdehyde levels in patients with social phobia. Psychiatry Res. (in press).
8. Deutsch SI, Rosse RB, Schwartz BL, Fay-McCarthy M, Rosenberg PB, Fearing K. Methylene blue adjuvant therapy of schizophrenia. Clin. Neuropharmacol. 1997; 20: 357-363.
9. Evans PH. Free radicals in brain metabolism and pathology. Br. Med. Bull. 1993; 49: 577-587.
10. Suzuki E, Yagi G, Nakaki T, Kanba S, Asai M. Elevated plasma nitrate levels in depressive states. J. Affect. Disord. 2001; 63: 221-224.
11. Giovannoni G, Heales SJ, Silver NC et al. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 1997; 145: 77-81.